Skip to main content

Table 4 Activity limitations determined using the AM.

From: Effect of tadalafil on blood flow, pain, and function in chronic cold Complex Regional Pain Syndrome: a randomized controlled trial

 

tadalafil

placebo

  
 

start

end

start

end

Pt

Pgt

% Time Standing

8.3 ± 2.8

10.7 ± 6.1

10.5 ± 4.3

10.3 ± 3.3

0.25

0.19

% Time Walking

4.5 ± 2.2

5.3 ± 2.8

5.6 ± 2.9

6.5 ± 3.8

0.15

0.88

% Time Upright

12.8 ± 4.5

16.0 ± 8.3

16.1 ± 7.0

16.9 ± 6.9

0.18

0.40

Number of Walking periods < 10 s

119.9 ± 50.8

138.7 ± 67.9

141.7 ± 81.8

146.4 ± 58.8

0.40

0.61

  1. The Activity Monitor measurements were taken over a 24-h period, and are given as mean ± SD. In all these measurements a higher value indicates better performance. The start and end times were when treatment started at t = 0 and ended at t = 12 weeks.
  2. Pt = P-value for differences over time; Pgt = P-value for interaction Group*Time
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us